View in EDS

51 Pilot study of weekly chemo-hormono-immunotherapy including cisplatin, epirubicin, medroxyprogesterone acetate + rIL-2, followed by docetaxel plus cisplatin in patients with advanced (Stage IIIB-IV) non-small-cell lung cancer (NSCLC)

Saved in:
Bibliographic Details
Title: 51 Pilot study of weekly chemo-hormono-immunotherapy including cisplatin, epirubicin, medroxyprogesterone acetate + rIL-2, followed by docetaxel plus cisplatin in patients with advanced (Stage IIIB-IV) non-small-cell lung cancer (NSCLC)
Authors: Mantovani, G., Massa, E., Madeddu, C., Gramignano, G., Astara, G., Lusso, M., Cherchi, V., Serpe, R.
Source: Lung Cancer (01695002). Jul2005 Supplement 2, Vol. 49, pS392-S392. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 19486233
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 51 Pilot study of weekly chemo-hormono-immunotherapy including cisplatin, epirubicin, medroxyprogesterone acetate + rIL-2, followed by docetaxel plus cisplatin in patients with advanced (Stage IIIB-IV) non-small-cell lung cancer (NSCLC)
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Mantovani%2C+G%2E%22">Mantovani, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Massa%2C+E%2E%22">Massa, E.</searchLink><br /><searchLink fieldCode="AR" term="%22Madeddu%2C+C%2E%22">Madeddu, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Gramignano%2C+G%2E%22">Gramignano, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Astara%2C+G%2E%22">Astara, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Lusso%2C+M%2E%22">Lusso, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Cherchi%2C+V%2E%22">Cherchi, V.</searchLink><br /><searchLink fieldCode="AR" term="%22Serpe%2C+R%2E%22">Serpe, R.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lung+Cancer+%2801695002%29%22">Lung Cancer (01695002)</searchLink>. Jul2005 Supplement 2, Vol. 49, pS392-S392. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=19486233
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/s0169-5002(05)81522-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S392
    Titles:
      – TitleFull: 51 Pilot study of weekly chemo-hormono-immunotherapy including cisplatin, epirubicin, medroxyprogesterone acetate + rIL-2, followed by docetaxel plus cisplatin in patients with advanced (Stage IIIB-IV) non-small-cell lung cancer (NSCLC)
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mantovani, G.
      – PersonEntity:
          Name:
            NameFull: Massa, E.
      – PersonEntity:
          Name:
            NameFull: Madeddu, C.
      – PersonEntity:
          Name:
            NameFull: Gramignano, G.
      – PersonEntity:
          Name:
            NameFull: Astara, G.
      – PersonEntity:
          Name:
            NameFull: Lusso, M.
      – PersonEntity:
          Name:
            NameFull: Cherchi, V.
      – PersonEntity:
          Name:
            NameFull: Serpe, R.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 07
              Text: Jul2005 Supplement 2
              Type: published
              Y: 2005
          Identifiers:
            – Type: issn-print
              Value: 01695002
          Numbering:
            – Type: volume
              Value: 49
          Titles:
            – TitleFull: Lung Cancer (01695002)
              Type: main
ResultId 1